NEU neuren pharmaceuticals limited

Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-9

  1. 4,027 Posts.
    lightbulb Created with Sketch. 991
    Early acceptance of NDA ~ brilliant
    No Advisory Committee expected ~ excellent

    Keep ticking the boxes NEU.
    Just a word of caution though. Nothing is a done deal with the FDA. Try not to get dizzy and starry eyed about rocket ship share price predictions by randoms on Hotcopper.

    It’s important to run your own race, do your own due diligence and make your own investment decisions. Hopefully we get lots of green today though!!

    DYOR and GLTAH
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.76
Change
0.170(1.17%)
Mkt cap ! $1.837B
Open High Low Value Volume
$14.36 $14.86 $14.25 $3.707M 254.0K

Buyers (Bids)

No. Vol. Price($)
1 2500 $14.70
 

Sellers (Offers)

Price($) Vol. No.
$14.80 1000 1
View Market Depth
Last trade - 16.10pm 16/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.